Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-15-004137
Filing Date
2015-03-05
Accepted
2015-03-05 12:34:14
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K oxfd20141231_10k.htm 10-K 3066112
2 EXHIBIT 21.1 ex21-1.htm EX-21.1 7722
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 3245
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 15170
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 15475
6 EXHIBIT 32 ex32.htm EX-32 6786
13 oxfd20141231_10kimg002.gif GRAPHIC 19610
14 img.jpg GRAPHIC 106334
  Complete submission text file 0001437749-15-004137.txt   15553053

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS oxfd-20141231.xml EX-101.INS 2219194
8 EXHIBIT 101.SCH oxfd-20141231.xsd EX-101.SCH 94860
9 EXHIBIT 101.CAL oxfd-20141231_cal.xml EX-101.CAL 71516
10 EXHIBIT 101.DEF oxfd-20141231_def.xml EX-101.DEF 530104
11 EXHIBIT 101.LAB oxfd-20141231_lab.xml EX-101.LAB 676067
12 EXHIBIT 101.PRE oxfd-20141231_pre.xml EX-101.PRE 519088
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36200 | Film No.: 15676515
SIC: 2835 In Vitro & In Vivo Diagnostic Substances